These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11175931)

  • 1. Methicillin resistant Staphylococcus aureus.
    Salaria M; Singh M
    Indian Pediatr; 2001 Jan; 38(1):29-36. PubMed ID: 11175931
    [No Abstract]   [Full Text] [Related]  

  • 2. New resistance in Staphylococcus aureus.
    Waldvogel FA
    N Engl J Med; 1999 Feb; 340(7):556-7. PubMed ID: 10021477
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin resistance in Staphylococcus aureus.
    John CC
    N Engl J Med; 1999 Jul; 341(3):207-8. PubMed ID: 10409039
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy for methicillin-resistant Staphylococcus aureus.
    Quintiliani R; Kuti J
    Conn Med; 2001 Jan; 65(1):23-5. PubMed ID: 11227621
    [No Abstract]   [Full Text] [Related]  

  • 5. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
    Sieradzki K; Roberts RB; Haber SW; Tomasz A
    N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472
    [No Abstract]   [Full Text] [Related]  

  • 6. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G; Kamath S; Hussain A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin.
    Tattevin P; Arvieux C; Michelet C
    Arch Intern Med; 2007 Jun; 167(11):1206; author reply 1208-9. PubMed ID: 17563033
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
    Sakoulas G; Moellering RC; Eliopoulos GM
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methicillin-resistant Staphylococcus aureus infection in a geriatric unit for acutely ill].
    Selva O'Callaghan A; San José Laporte A; Almirante Gragera B; Vilardell Tarrés M
    Med Clin (Barc); 1998 May; 110(17):678. PubMed ID: 9656216
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is the vancomycin resistance of Staphylococcus aureus left unnoticed?].
    Vuento R
    Duodecim; 1999; 115(19):2045-7. PubMed ID: 11941798
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methicillin-resistant Staphylococcus aureus (MRSA) -- case report].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):581; quiz 589-92. PubMed ID: 15761786
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteomyelitis of the maxilla caused by methicillin-resistant Staphylococcus aureus.
    Cohen MA; Embil JM; Canosa T
    J Oral Maxillofac Surg; 2003 Mar; 61(3):387-90. PubMed ID: 12618981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.